Seminars in Thrombosis and Hemostasis

LinksSchließen

Referenz

Breet NJ, van Werkum JW, Bouman HJ. , et al.
High on-treatment platelet reactivity to both aspirin and clopidogrel is associated with the highest risk of adverse events following percutaneous coronary intervention.

Heart 2011;
97 (12) 983-990

Bibliographische Angaben herunterladen

Aufrufen in: